Dietary trial in prostate cancer: Early experience and implications for clinical trial design.
暂无分享,去创建一个
P. Carroll | W. Fair | D. Ornish | K. L. Lee | E. Pettengill
[1] W. Fair. Willet F. Whitore, Jr. Lecture: back to the future--the role of complementary medicine in urology. , 1999, The Journal of urology.
[2] T. Hurley,et al. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. , 1998, Journal of the National Cancer Institute.
[3] A. Cnaan,et al. Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma. , 1998, American journal of clinical pathology.
[4] P. Carroll,et al. Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity. , 1998, The Journal of urology.
[5] Meir J. Stampfer,et al. Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study , 1998 .
[6] M. Stampfer,et al. Prospective study of sex hormone levels and risk of prostate cancer. , 1996, Journal of the National Cancer Institute.
[7] H. Thaler,et al. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. , 1995, Journal of the National Cancer Institute.
[8] B. Henderson,et al. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. , 1991, British Journal of Cancer.